Voya Investment Management LLC Zai Lab LTD Transaction History

Voya Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $18,971 - $30,206	628 Added 6.97%	9,641 $320,000
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $9,870 - $17,148	443 Added 5.17%	9,013 $276,000
Q3 2022 Mar 03, 2023	SELL	$34.2 - $51.69 $15,150 - $22,898	-443 Reduced 4.92%	8,570 $293,000
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $9,028 - $13,646	-264 Reduced 2.99%	8,570 $293,000
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $2,152 - $4,620	93 Added 1.06%	8,834 $306,000
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $26,936 - $62,468	970 Added 12.48%	8,741 $384,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $42,840 - $72,774	-408 Reduced 4.99%	7,771 $819,000
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $169,273 - $243,540	1,353 Added 19.82%	8,179 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $88,986 - $146,979	1,086 Added 18.92%	6,826 $924,000
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $78,577 - $95,922	1,072 Added 22.96%	5,740 $477,000
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $227,891 - $385,250	4,668 New	4,668 $383,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.